EMBL-EBI provides freely available data from life science experiments, performs basic research in computational biology and offers an extensive user training programme, supporting researchers in academia and industry.
News from EMBL-EBI
Connecting life science research across the Atlantic
The Centre for Therapeutic Target Validation is a novel scientific collaboration that will use genomics and big data to drive drug discovery.
The ProteomeXchange consortium has launched a public portal for exchanging proteomics data and information. The integrating service highlights a growing trend in the sharing of data generated in mass-spectrometry experiments.
The Industry Programme is a forum for interaction between EMBL-EBI and the industrial life-science research sector. Our member organisations, which include pharmaceutical and agribusiness companies, engage with EMBL-EBI in the latest bioinformatics research, service and standards development as well as training and pre-competitive projects. We also support small and medium-sized enterprises through our SME Forum.
EMBL-EBI is a pivotal partner in ELIXIR, the European life sciences infrastructure for biological information, as part of the European Strategy on Research Infrastructures (ESFRI) process. On behalf of ELIXIR, EMBL-EBI coordinates BioMedBridges, which develops technical bridges for interoperability between data and services in the ESFRI biomedical sciences research infrastructures. These collaborative projects are undertaken with our partners in the European Member States.